Matsuda Kenichiro, Sakurada Kaori, Mouri Wataru, Saino Makoto, Sato Shinya, Saito Shinjiro, Kayama Takamasa, Nakazato Yoichi
Department of Neurosurgery, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.
Brain Nerve. 2007 Aug;59(8):881-6.
Diffuse astrocytomas are classified as WHO Grade II tumors. Recently, a subtype presenting with better prognosis has been proposed, and it is known as "isomorphic astrocytoma." A clinical case that we encountered was believed to be categorized as this subtype; it has been presented in this report. The patient was a 20-year-old male with a chief complaint of intractable epileptic seizures. He experienced his first attack at 16 years of age in July 2001, and it was a generalized seizure. Anticonvulsants prescribed by a previous doctor had no effect on controlling the seizures. MRI performed in March 2004 showed a lesion approximately 2.0 cm in diameter in the left temporal lobe. The patient was referred to our institution for further investigation of the lesion and therapy. Electroencephalography and magnetoencephalography were used to assess the lesion at seizure focus. The tumor was resected under awake surgery. The pathological diagnosis was diffuse astrocytoma, but this tumor was considered to be the isomorphic subtype. Some parts of the tumor showed a relatively high MIB-1 labeling index (LI) of 9.2%, and additional 50-Gy radiotherapy was performed. The postoperative course was uneventful and despite decreasing the anticonvulsant dosage, he has remained seizure free. Isomorphic astrocytoma is characterized by prolonged epileptic seizures, a low MIB-1 LI, and better prognosis. In our case, since the MIB-1 LI was higher in some parts of the tumor, the appropriate therapy for WHO Grade II tumors was performed. However, this case was considered representative of isomorphic astrocytoma. No reports of this tumor subtype have been previously described in Japan. Therefore, this report is the first case of isomorphic astrocytoma reported to Japanese literature.
弥漫性星形细胞瘤被归类为世界卫生组织(WHO)二级肿瘤。最近,有人提出了一种预后较好的亚型,即“同形性星形细胞瘤”。我们遇到的一例临床病例被认为属于该亚型,现将其报告如下。患者为20岁男性,主要症状为顽固性癫痫发作。他于2001年7月16岁时首次发作,为全身性发作。先前医生开的抗惊厥药对控制发作无效。2004年3月进行的磁共振成像(MRI)显示左颞叶有一个直径约2.0厘米的病灶。患者被转诊至我院进一步检查病灶并接受治疗。采用脑电图和脑磁图评估癫痫发作灶的病灶情况。在清醒手术下切除肿瘤。病理诊断为弥漫性星形细胞瘤,但该肿瘤被认为是同形性亚型。肿瘤的某些部分显示相对较高的MIB-1标记指数(LI),为9.2%,随后进行了50 Gy的额外放疗。术后过程顺利,尽管减少了抗惊厥药的剂量,但他一直未再发作。同形性星形细胞瘤的特点是癫痫发作时间延长、MIB-1 LI较低且预后较好。在我们的病例中,由于肿瘤某些部分的MIB-1 LI较高,因此对WHO二级肿瘤进行了适当的治疗。然而,该病例被认为是同形性星形细胞瘤的典型代表。此前日本尚未有关于这种肿瘤亚型的报道。因此,本报告是日本文献中首次报道的同形性星形细胞瘤病例。